share_log

賽生藥業：根據收購守則規則3.8刊發的公告

SCICLONE PHARMA: ANNOUNCEMENT PURSUANT TO RULE 3.8 OF THE TAKEOVERS CODE

Hong Kong Stock Exchange ·  Apr 26 09:43
Summary by Moomoo AI
賽生藥業控股有限公司於2024年4月26日發布公告，提及Silver Pegasus Investment Limited建議以協議安排方式私有化賽生藥業。公告回顧了與私有化相關的一系列事件，包括2024年3月28日的聯合公告，以及公司的購股權激勵計劃和首次公開發售後購股權計劃。此外，公告披露了因行使購股權而新增的286,400股股份，使得公司的已發行股份總數達到628,768,032股。同時，公司還擁有68,043,232份購股權。執行董事、首席執行官兼總裁趙宏及其他董事成員對公告內容的準確性承擔責任，並確認公告中無任何遺漏事實。
賽生藥業控股有限公司於2024年4月26日發布公告，提及Silver Pegasus Investment Limited建議以協議安排方式私有化賽生藥業。公告回顧了與私有化相關的一系列事件，包括2024年3月28日的聯合公告，以及公司的購股權激勵計劃和首次公開發售後購股權計劃。此外，公告披露了因行使購股權而新增的286,400股股份，使得公司的已發行股份總數達到628,768,032股。同時，公司還擁有68,043,232份購股權。執行董事、首席執行官兼總裁趙宏及其他董事成員對公告內容的準確性承擔責任，並確認公告中無任何遺漏事實。
Caisang Pharmaceutical Holdings Limited issued a notice on 26 April 2024 mentioning Silver Pegasus Investment Limited's proposal to privatize its pharmaceutical business by agreement. The announcement reviews a series of events related to the privatization, including the joint announcement of March 28, 2024, as well as the Company's Share Option Incentive Program and Initial Public Offering Possession. IN ADDITION, THE ANNOUNCEMENT DISCLOSED 286,400 SHARES ADDED AS A RESULT OF THE EXERCISE OF SHARE OPTIONS, BRINGING THE COMPANY'S TOTAL ISSUED SHARES TO 628,768,032 SHARES. At the same time, the company also holds 68,043,232 share options. The Executive Director, Chief Executive Officer and President Zhao Hong and other members of the Board are responsible for the accuracy of the contents of the announcement and confirm that there are no omissions in the announcement.
Caisang Pharmaceutical Holdings Limited issued a notice on 26 April 2024 mentioning Silver Pegasus Investment Limited's proposal to privatize its pharmaceutical business by agreement. The announcement reviews a series of events related to the privatization, including the joint announcement of March 28, 2024, as well as the Company's Share Option Incentive Program and Initial Public Offering Possession. IN ADDITION, THE ANNOUNCEMENT DISCLOSED 286,400 SHARES ADDED AS A RESULT OF THE EXERCISE OF SHARE OPTIONS, BRINGING THE COMPANY'S TOTAL ISSUED SHARES TO 628,768,032 SHARES. At the same time, the company also holds 68,043,232 share options. The Executive Director, Chief Executive Officer and President Zhao Hong and other members of the Board are responsible for the accuracy of the contents of the announcement and confirm that there are no omissions in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more